Cargando…
Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
BACKGROUND: Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZH), and to investigate the underlying mechanisms by integrating transcriptional...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246043/ https://www.ncbi.nlm.nih.gov/pubmed/37280673 http://dx.doi.org/10.1186/s12935-023-02946-2 |
_version_ | 1785054967254482944 |
---|---|
author | Yan, Xiangying Liu, Yudong Li, Congchong Mao, Xia Xu, Tengteng Hu, Zhixing Zhang, Chu Lin, Na Lin, Ya Zhang, Yanqiong |
author_facet | Yan, Xiangying Liu, Yudong Li, Congchong Mao, Xia Xu, Tengteng Hu, Zhixing Zhang, Chu Lin, Na Lin, Ya Zhang, Yanqiong |
author_sort | Yan, Xiangying |
collection | PubMed |
description | BACKGROUND: Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZH), and to investigate the underlying mechanisms by integrating transcriptional regulatory network analysis and experimental validation. METHODS: A diethylnitrosamine (DEN)-induced HCC model in rats was established and used to evaluate the anti-cancer efficacy of PZH. After detecting a transcriptomic profiling, the “disease-related gene–drug effective target” interaction network was constructed, and the candidate targets of PZH against malignant transformation from hepatic fibrosis to HCC were identified and verified in vitro. RESULTS: PZH effectively alleviated the pathological changes of hepatic fibrosis and cirrhosis, and inhibited tumor formation and growth in DEN-induced HCC rats. Additionally, the administration of PZH reduced the levels of various hepatic function-related serological indicators significantly. Mechanically, a ferroptosis-related SLC7A11-GSH-GPX4 axis might be one of potential targets of PZH against malignant transformation from hepatic fibrosis to HCC. Especially, high SLC7A11 expression may be associated with poor prognosis of HCC patients. Experimentally, the administration of PZH markedly increased the trivalent iron and ferrous ion, suppressed the expression levels of SLC7A11 and GPX4 proteins, and reduced the GSH/GSSG ratio in the liver tissues of DEN-induced HCC rats. CONCLUSIONS: Our data offer an evidence that PZH may effectively improve the hepatic fibrosis microenvironment and prevent the occurrence of HCC through promoting ferroptosis in tumor cells via inhibiting the SLC7A11-GSH-GPX4 axis, implying that PZH may be a potential candidate drug for prevention and treatment of HCC at an early stage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02946-2. |
format | Online Article Text |
id | pubmed-10246043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102460432023-06-08 Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis Yan, Xiangying Liu, Yudong Li, Congchong Mao, Xia Xu, Tengteng Hu, Zhixing Zhang, Chu Lin, Na Lin, Ya Zhang, Yanqiong Cancer Cell Int Research BACKGROUND: Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZH), and to investigate the underlying mechanisms by integrating transcriptional regulatory network analysis and experimental validation. METHODS: A diethylnitrosamine (DEN)-induced HCC model in rats was established and used to evaluate the anti-cancer efficacy of PZH. After detecting a transcriptomic profiling, the “disease-related gene–drug effective target” interaction network was constructed, and the candidate targets of PZH against malignant transformation from hepatic fibrosis to HCC were identified and verified in vitro. RESULTS: PZH effectively alleviated the pathological changes of hepatic fibrosis and cirrhosis, and inhibited tumor formation and growth in DEN-induced HCC rats. Additionally, the administration of PZH reduced the levels of various hepatic function-related serological indicators significantly. Mechanically, a ferroptosis-related SLC7A11-GSH-GPX4 axis might be one of potential targets of PZH against malignant transformation from hepatic fibrosis to HCC. Especially, high SLC7A11 expression may be associated with poor prognosis of HCC patients. Experimentally, the administration of PZH markedly increased the trivalent iron and ferrous ion, suppressed the expression levels of SLC7A11 and GPX4 proteins, and reduced the GSH/GSSG ratio in the liver tissues of DEN-induced HCC rats. CONCLUSIONS: Our data offer an evidence that PZH may effectively improve the hepatic fibrosis microenvironment and prevent the occurrence of HCC through promoting ferroptosis in tumor cells via inhibiting the SLC7A11-GSH-GPX4 axis, implying that PZH may be a potential candidate drug for prevention and treatment of HCC at an early stage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02946-2. BioMed Central 2023-06-06 /pmc/articles/PMC10246043/ /pubmed/37280673 http://dx.doi.org/10.1186/s12935-023-02946-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yan, Xiangying Liu, Yudong Li, Congchong Mao, Xia Xu, Tengteng Hu, Zhixing Zhang, Chu Lin, Na Lin, Ya Zhang, Yanqiong Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis |
title | Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis |
title_full | Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis |
title_fullStr | Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis |
title_full_unstemmed | Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis |
title_short | Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis |
title_sort | pien-tze-huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting slc7a11-gsh-gpx4 axis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246043/ https://www.ncbi.nlm.nih.gov/pubmed/37280673 http://dx.doi.org/10.1186/s12935-023-02946-2 |
work_keys_str_mv | AT yanxiangying pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT liuyudong pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT licongchong pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT maoxia pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT xutengteng pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT huzhixing pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT zhangchu pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT linna pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT linya pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis AT zhangyanqiong pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis |